BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 28941300)

  • 21. Trypanosoma cruzi infection in a Spanish liver transplant recipient.
    Rodriguez-Guardado A; González ML; Rodriguez M; Flores-Chavez M; Boga JA; Gascon J
    Clin Microbiol Infect; 2015 Jul; 21(7):687.e1-3. PubMed ID: 25882355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease].
    Meira WS; de Castro AM; Gontijo ED; Rassi A; Luquetti AO; Machado-Coelhos GL; Chiari E; Galvão LM
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():107-9. PubMed ID: 17605216
    [No Abstract]   [Full Text] [Related]  

  • 23. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes.
    Miyamoto CT; Gomes ML; Marangon AV; Araújo SM; Bahia MT; Lana M; Toledo MJ
    Exp Parasitol; 2006 Mar; 112(3):198-201. PubMed ID: 16376332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.
    Basquiera AL; Sembaj A; Aguerri AM; Omelianiuk M; Guzmán S; Moreno Barral J; Caeiro TF; Madoery RJ; Salomone OA
    Heart; 2003 Oct; 89(10):1186-90. PubMed ID: 12975414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing Parasite Load in Chagas Disease Patients by Quantitative Multiplex Real-Time PCR.
    Ramírez JC; da Cruz Moreira O
    Methods Mol Biol; 2019; 1955():215-225. PubMed ID: 30868530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Chagas disease: Quantification of Trypanosoma cruzi in peripheral blood and dejections of Triatoma infestans fed by xenodiagnosis in patients with and without cardiopathy.
    Apt W; Carrasco D; Fuentealba C; Canals M; Muñoz G; Saavedra M; Castillo JP; Zulantay I
    Acta Trop; 2019 Dec; 200():105167. PubMed ID: 31513762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.
    Leiby DA; Herron RM; Garratty G; Herwaldt BL
    J Infect Dis; 2008 Aug; 198(4):609-13. PubMed ID: 18588482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive role of polymerase chain reaction in the early diagnosis of congenital Trypanosoma cruzi infection.
    Velázquez EB; Rivero R; De Rissio AM; Malagrino N; Esteva MI; Riarte AR; Ruiz AM
    Acta Trop; 2014 Sep; 137():195-200. PubMed ID: 24892867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case Report: Successful Lung Transplantation from a Donor Seropositive for
    Salvador F; Sánchez-Montalvá A; Sulleiro E; Berastegui C; Jauregui A; Pont T; Los-Arcos I; Len Ó; Gavaldà J; Molina I
    Am J Trop Med Hyg; 2017 Oct; 97(4):1147-1150. PubMed ID: 28749767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.
    Muñoz C; Zulantay I; Apt W; Ortiz S; Schijman AG; Bisio M; Ferrada V; Herrera C; Martínez G; Solari A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4518-23. PubMed ID: 23836179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children.
    Bua J; Volta BJ; Perrone AE; Scollo K; Velázquez EB; Ruiz AM; De Rissio AM; Cardoni RL
    PLoS Negl Trop Dis; 2013; 7(10):e2476. PubMed ID: 24147166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review.
    Carvalho NB; Freitas VLT; Seguro FS; Bezerra RC; Fatobene G; Nakanishi ÉYS; Visnadi H; Martinez G; Batista MV; Rocha V; Dulley FL; Costa SF; Shikanai-Yasuda MA
    Rev Inst Med Trop Sao Paulo; 2024; 66():e10. PubMed ID: 38324876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Trypanosoma cruzi parasitic load by real-time PCR and blood culture in long-term kidney transplant recipients.
    Jesus Guimarães Ferreira J; Antonio de Almeida E; Barbosa Marcon GE; Gonçalves Lima R; Barroso Pereira M; Ramos Gadelha F; Mazzali M; Martins LC; Silva Wanderley J; Botelho Costa SC
    J Infect Dev Ctries; 2021 Nov; 15(11):1774-1781. PubMed ID: 34898511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease.
    Barcán L; Luna C; Clara L; Sinagra A; Valledor A; De Rissio AM; Gadano A; García MM; de Santibañes E; Riarte A
    Liver Transpl; 2005 Sep; 11(9):1112-6. PubMed ID: 16123968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An autopsy-based study of Trypanosoma cruzi persistence in organs of chronic chagasic patients and its relevance for transplantation.
    Benvenuti LA; Roggério A; Cavalcanti MM; Nishiya AS; Levi JE
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28945308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report.
    Souza FF; Castro-E-Silva O; Marin Neto JA; Sankarankutty AK; Teixeira AC; Martinelli AL; Gaspar GG; Melo L; Figueiredo JF; Romano MM; Maciel BC; Passos AD; Rossi MA
    Transplant Proc; 2008 Apr; 40(3):875-8. PubMed ID: 18455041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City.
    Rodríguez-Romo R; Morales-Buenrostro LE; Reyes PA; Gracida C; Medeiros M; Mancilla E; De Leo C; Alberú J
    Transpl Infect Dis; 2013 Dec; 15(6):639-44. PubMed ID: 23901935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of Trypanosoma cruzi parasitemia among infected blood donors with a potential association between parasite lineage and transfusion transmission.
    Leiby DA; Nguyen ML; Proctor MC; Townsend RL; Stramer SL
    Transfusion; 2017 Jun; 57(6):1426-1432. PubMed ID: 28295355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.